Immediate Impact
72 standout
Citing Papers
Alcohol-associated liver disease
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of David Chromy being referenced
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Chromy | 596 | 594 | 88 | 47 | 660 | |
| Angelo Rossini | 492 | 523 | 64 | 37 | 748 | |
| Raimondo Cerini | 444 | 492 | 193 | 31 | 688 | |
| J. Kirschner | 669 | 613 | 43 | 24 | 782 | |
| Ayman Yosry | 463 | 436 | 107 | 58 | 733 | |
| Zheng Zeng | 436 | 338 | 100 | 52 | 752 | |
| B. Berris | 422 | 334 | 34 | 42 | 596 | |
| Chengbo Yu | 362 | 347 | 109 | 37 | 667 | |
| Aisha Elsharkawy | 614 | 623 | 42 | 60 | 799 | |
| Kubilay Çınar | 351 | 345 | 92 | 45 | 597 | |
| C. Vandelli | 501 | 513 | 46 | 26 | 660 |
All Works
Login with ORCID to disown or claim papers
Loading papers...